Off-Label Communications Bill Allowing Discussion Of Unapproved Drugs Advances
Safe harbor for off label discussions between manufacturers and payers clears US House Energy & Commerce Health Subcommittee. Bill covers unapproved drugs as well as off label uses for approved agents.